Antisense compounds, compositions and methods are provided for modulating the expression of VEGF-B. The compositions comprise antisense compounds, particularly antisense oligonucleotides, targeted to nucleic acids encoding VEGF-B. Methods of using these compounds for modulation of VEGF-B expression and for treatment of diseases associated with expression of VEGF-B are provided.
申请公布号
WO03105754(A2)
申请公布日期
2003.12.24
申请号
WO2003US16215
申请日期
2003.06.16
申请人
ISIS PHARMACEUTICALS INC.;ZHANG, HONG;DOBIE, KENNETH, W.